PLRX
Pliant Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Pliant Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Pliant Therapeutics, Inc.
0.85
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Tang Capital ManagementTang | $7.0M | 12.72% | −0.03% | |
| 2 | ADAR1 Capital ManagementADAR1 | $6.3M | 11.42% | +113.13% | |
| 3 | Vanguard Capital ManagementVanguardindex-like | $2.8M | 5.06% | +4.15% | |
| 4 | Acadian Asset ManagementAcadian | $2.8M | 5.01% | 0.00% | |
| 5 | Two Sigma InvestmentsTwo Sigma | $2.6M | 4.69% | +0.43% | |
| 6 | Citadel AdvisorsCitadel | $2.4M | 4.44% | −34.36% | |
| 7 | Renaissance TechnologiesRenaissance Technologies | $2.3M | 4.25% | +10.63% | |
| 8 | Monaco Asset Management SAMMonaco Asset Management SAM | $2.2M | 4.02% | 0.00% | |
| 9 | Lynx1 Capital ManagementLynx1 | $2.0M | 3.73% | new | |
| 10 | BML Capital ManagementBML | $1.8M | 3.20% | 0.00% | |
| 11 | Prosight ManagementProsight | $1.6M | 2.84% | −17.83% | |
| 12 | Peapod Lane CapitalPeapod Lane Capital | $1.5M | 2.71% | +1.59% | |
| 13 | Woodline PartnersWoodline Partners | $1.5M | 2.69% | −22.22% | |
| 14 | BlackRockBlackRockindex-like | $1.3M | 2.39% | +5.00% | |
| 15 | Ikarian CapitalIkarian Capital | $1.1M | 2.07% | new | |
| 16 | Eversept PartnersEversept Partners | $1.0M | 1.85% | 0.00% | |
| 17 | Marshall WaceMarshall Wace | $952,041 | 1.73% | −16.15% | |
| 18 | Redmile GroupRedmile | $880,224 | 1.60% | 0.00% | |
| 19 | JPMorgan ChaseJPMorgan Chase | $783,894 | 1.42% | −20.91% | |
| 20 | Jacobs Levy Equity ManagementJacobs Levy Equity | $733,157 | 1.33% | −10.50% | |
| 21 | Geode Capital ManagementGeodeindex-like | $659,954 | 1.20% | +38.66% | |
| 22 | UBS GroupUBS | $651,806 | 1.18% | −45.96% | |
| 23 | Millennium ManagementMillennium | $637,770 | 1.16% | −52.61% | |
| 24 | Bridgeway Capital ManagementBridgeway | $631,138 | 1.15% | 0.00% | |
| 25 | Connor, Clark & Lunn Investment ManagementConnor, Clark & Lunn | $611,132 | 1.11% | +3.60% |
85 managers report $55.0M of Pliant Therapeutics on form 13F for the quarter ended Jun 30 '26. 21 of them hold 80% of it; Tang is largest at 12.72%.
Linked news
NewsExpected move
No implied move.
No implied move.
No implied move.